ANAGENICS LIMITED — Director's Dealing 2019

Nov 21, 2019

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Cellmid Limited
ABN	69 111 304 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Ms Maria Halasz
Date of last notice	7 June 2019

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Direct Capital Group Pty Ltd and Direct Capital Pty Ltd – Entities controlled by the Director
Date of change	20 November 2019
No. of securities held prior to change	Direct 420,000 fully paid ordinary shares Indirect 1,599,938 fully paid ordinary shares
Class	Fully paid ordinary shares; and Unlisted and unvested options
Number acquired	600,000 fully paid ordinary shares 3,000,000 unlisted and unvested options
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Fully paid ordinary shares - $0.20 per share (total value of $120,000) Unlisted and unvested options-nil

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	Direct 420,000 fully paid ordinary shares Indirect 2,199,938 fully paid ordinary shares 3,000,000 unlisted and unvested options
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Fully paid ordinary shares – participation in Placement as approved by shareholders at the 2019 Annual General Meeting held on 19 November 2019. Unlisted and unvested options – issued as short and long term incentives as approved by shareholders at the 2019 Annual General Meeting held on 19 November 2019.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 3